EGFR and ErbB2 differentially regulate Raf-1 translocation and activation

Laboratory Investigation

Volumn 82, Issue 1, 2002, Pages 71-78

  Zhang, Lianfeng ^a   Bewick, Mary ^a   Lafrenie, Robert M ^a  

^a N E Ontario Regional Cancer Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; RAF PROTEIN; RAF1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MEMBRANE VESICLE; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0036144903     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780396     Document Type: Article

References (41)

1. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma
2. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy
3. Oncogenes and signal transduction
4. Receptors for epidermal growth factor and other polypeptide mitogens
5. Extracellular signals and reversible protein phosphorylation: What to Mek of it all
6. Inactivation of raf-1 by a protein-tyrosine phosphatase stimulated by GTP and reconstituted by Gαi/o subunits
7. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma
8. Heterodimeriza tion and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
9. Het erodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: A mechanism for receptor transregu lation
10. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling
11. Mutational activa tion of c-raf-1 and definition of the minimal transforming sequence
12. Dimerization of cell surface receptors in signal transduction
13. Identification of heregulin, a specific activator of p185erbB2
14. B-raf, a new member of the raf family, is activated by DNA rearrangement
15. Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2
16. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer
17. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3
18. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases
19. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
20. Require ment for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
21. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
22. Prognostic value of amplification of c-erb-B2 in bladder carcinoma
23. Signal transduction. Hot lips and phosphorylation of protein kinases
24. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane
25. Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins
26. The complexity of Raf-1 regulation
27. The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas
28. Prognostic value of Lauren classification and c-erbB-2 oncogene over expression in adenocarcinoma of the esophagus and gastro esophageal junction
29. HER-2/neu (c-erb-B2) gene and protein in breast cancer
30. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary
31. Function of Ras as a molecular switch in signal transduction
32. Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis
33. Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer
34. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
35. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
36. Endocytosis of growth factor receptors
37. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis
38. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential inhuman breast cancer cells without increasing their transformation abilities
39. Mammalian Ras interacts directly with the serine/threonine kinase Raf
40. Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function
41. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation